Akso Health vs Ryde
AHG and RYDE side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AHG and RYDE compare
Ryde grew revenue faster over the last twelve months (39.7% versus −6.4% for Akso Health).
Akso Health keeps more of each dollar of sales as profit, with a net margin of −135% compared with −140% at Ryde.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AHG | RYDE |
|---|---|---|
| Size and price | ||
| Share price | $1.35 | $0.935 |
| Change, 1 year | −14.0% | 98.9% |
| Change, 5 years | −53.9% | – |
| Beta (5Y) | 0.55 | −0.87 |
| Employees | 12 | 25 |
| StockData Score | ||
| Total score | 7 | 7 |
| Valuation score | 0 | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 1 (better) | 0 |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | −6.4% | 39.7% (better) |
| Revenue growth, 5Y average | 51.1% | – |
| EPS growth (TTM) | −93.8% | – |
| Profitability | ||
| Gross margin | −0.08% | – |
| Operating margin | −150% | −50.1% (better) |
| Net margin | −135% (better) | −140% |
| FCF margin | −92.5% (better) | −188% |
| Return on equity | −9.8% (better) | −64.8% |
| Return on invested capital | −16.1% (better) | −20.7% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 21.77 (better) | 9.60 |
| Piotroski F-score | 5 (better) | 4 |
| Dividends and buybacks | ||
| Years of dividend growth | – | 0 |
| Ownership | ||
| Held by institutions | 0.01% | 0.22% |
| Held by insiders | 0.00% | 49.0% |
| Insider net buying, 12 months | – | −$526K |
Go deeper
- AHG stock overview
- AHG income statement
- AHG valuation and score
- RYDE stock overview
- RYDE income statement
- RYDE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.